Compare UNB & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | XTNT |
|---|---|---|
| Founded | 1891 | N/A |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.6M | 86.2M |
| IPO Year | N/A | N/A |
| Metric | UNB | XTNT |
|---|---|---|
| Price | $24.39 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 13.7K | ★ 187.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $10.03 | $52.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.65 | $0.34 |
| 52 Week High | $36.00 | $0.95 |
| Indicator | UNB | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 42.27 |
| Support Level | $23.85 | $0.55 |
| Resistance Level | $25.58 | $0.65 |
| Average True Range (ATR) | 0.64 | 0.04 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 48.48 | 41.82 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.